Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Kim C. E. Sigaloff"'
Autor:
Jara R. de la Court, Jarom Heijmans, Jennifer Huynh, Elske Sieswerda, Nick A. de Jonge, Karin van Dijk, Kim C. E. Sigaloff, Rogier P. Schade
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 11, Iss 1, Pp 1-10 (2022)
Abstract Background In neutropenic patients, bloodstream infections (BSI) significantly contribute to morbidity and mortality. Appropriate empirical antibiotic therapy (EAT) of BSI is essential, at the same time overconsumption of very broad-spectrum
Externí odkaz:
https://doaj.org/article/c29463ab35e942179571646d610d9344
Autor:
Jara R. de la Court, Sjoukje H. S. Woudt, Annelot F. Schoffelen, Jarom Heijmans, Nick A. de Jonge, Tjomme van der Bruggen, Marije K. Bomers, Merel M. C. Lambregts, Rogier P. Schade, Kim C. E. Sigaloff, ISIS-AR study group
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Objectives Among patients with haematological malignancy, bacteraemia is a common complication during chemotherapy-induced neutropenia. Resistance of gram-negative bacteria (GNB) to third-generation cephalosporins (3GC) is increasing. In ord
Externí odkaz:
https://doaj.org/article/d8aa07ea528d476fb6a250555d1db359
Autor:
Annemieke K. van den Broek, Jara R. de la Court, Thomas Groot, Reinier M. van Hest, Caroline E. Visser, Kim C. E. Sigaloff, Rogier P. Schade, Jan M. Prins
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract Objectives Evaluation of the appropriateness of the duration of antimicrobial treatment is a cornerstone of antibiotic stewardship programs, but it is time-consuming. Furthermore, it is often restricted to antibiotics prescribed during hospi
Externí odkaz:
https://doaj.org/article/e6807a4ff13e49bdbeba4c120aecc545
Autor:
Rashudy F. Mahomedradja, Tessa O. van den Beukel, Maaike van den Bos, Steven Wang, Kirsten A. Kalverda, Birgit I. Lissenberg-Witte, Marianne A. Kuijvenhoven, Esther J. Nossent, Majon Muller, Kim C. E. Sigaloff, Jelle Tichelaar, Michiel A. van Agtmael
Publikováno v:
BMC Emergency Medicine, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has challenged healthcare globally. An acute increase in the number of hospitalized patients has necessitated a rigoro
Externí odkaz:
https://doaj.org/article/66cb454ad6874cd78b46f6d4e85323b2
Autor:
Sophie Coenen, Jara R. de la Court, David T. P. Buis, Lilian J. Meijboom, Rogier P. Schade, Caroline E. Visser, Reinier van Hest, Marianne Kuijvenhoven, Jan M. Prins, Suzan F. M. Nijman, Elske Sieswerda, Kim C. E. Sigaloff
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-10 (2021)
Abstract Background We defined the frequency of respiratory community-acquired bacterial co-infection in patients with COVID-19, i.e. patients with a positive SARS-CoV-2 PCR or a COVID-19 Reporting and Data System (CO-RADS) score ≥ 4, based on a co
Externí odkaz:
https://doaj.org/article/798cfdb2a04d4d25a44cb312a37c445a
Autor:
Seth C. Inzaule, Cissy M. Kityo, Margaret Siwale, Alani Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Pascale Ondoa, Kim C. E. Sigaloff, Denise Naniche, Tobias F. Rinke de Wit, Raph L. Hamers
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-7 (2018)
Abstract In ART programs in sub-Saharan Africa, a growing proportion of HIV-infected persons initiating first-line antiretroviral therapy (ART) have a history of prior antiretroviral drug use (PAU). We assessed the effect of PAU on the risk of pre-tr
Externí odkaz:
https://doaj.org/article/0647a6dbb601463f9750fafd510d38ea
Autor:
T. Sonia Boender, Kim C. E. Sigaloff, Joshua Kayiwa, Victor Musiime, Job C. J. Calis, Raph L. Hamers, Lillian Katumba Nakatudde, Elizabeth Khauda, Andrew Mukuye, James Ditai, Sibyl P. Geelen, Peter Mugyenyi, Tobias F. Rinke de Wit, Cissy Kityo
Publikováno v:
AIDS Research and Treatment, Vol 2012 (2012)
Although the advantages of early infant HIV diagnosis and treatment initiation are well established, children often present late to HIV programs in resource-limited settings. We aimed to assess factors related to the timing of treatment initiation am
Externí odkaz:
https://doaj.org/article/e459252990814f8eb915002b84e85d0f
Autor:
Lotte Haverman, Suzanne E Geerlings, Kevin Moody, Marc van der Valk, Pythia T Nieuwkerk, Kim C E Sigaloff, Maarten Bedert, Jeannine F Nellen, Annouschka Weijsenfeld, Laura Laan, Claire Bruins, Hedy van Oers
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Introduction Successful antiviral therapy has transformed HIV infection into a chronic condition, where optimising quality of life (QoL) has become essential for successful lifelong treatment. Patient-reported outcome measures (PROMs) can signal pote
Externí odkaz:
https://doaj.org/article/bd6f37ac16594f85acb07d576f2259a3
Autor:
Marlou J Jongkees, Daryl Geers, Kathryn S Hensley, Wesley Huisman, Corine H GeurtsvanKessel, Susanne Bogers, Lennert Gommers, Grigorios Papageorgiou, Simon P Jochems, Jan G den Hollander, Emile F Schippers, Heidi S M Ammerlaan, Wouter F W Bierman, Marc van der Valk, Marvin A H Berrevoets, Robert Soetekouw, Nienke Langebeek, Anke H W Bruns, Eliane M S Leyten, Kim C E Sigaloff, Marit G A van Vonderen, Corine E Delsing, Judith Branger, Peter D Katsikis, Yvonne M Mueller, Rory D de Vries, Bart J A Rijnders, Kees Brinkman, Casper Rokx, Anna H E Roukens
Publikováno v:
The Journal of Infectious Diseases, 227(5), 651-662. OXFORD UNIV PRESS INC
The Journal of Infectious Diseases, 227(5), 651-662. Oxford University Press
Jongkees, M J, Geers, D, Hensley, K S, Huisman, W, GeurtsvanKessel, C H, Bogers, S, Gommers, L, Papageorgiou, G, Jochems, S P, den Hollander, J G, Schippers, E F, Ammerlaan, H S M, Bierman, W F W, van der Valk, M, Berrevoets, M A H, Soetekouw, R, Langebeek, N, Bruns, A H W, Leyten, E M S, Sigaloff, K C E, van Vonderen, M G A, Delsing, C E, Branger, J, Katsikis, P D, Mueller, Y M, de Vries, R D, Rijnders, B J A, Brinkman, K, Rokx, C & Roukens, A H E 2023, ' Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination ', The Journal of infectious diseases, vol. 227, no. 5, pp. 651-662 . https://doi.org/10.1093/infdis/jiac451
The Journal of infectious diseases, 227(5), 651-662. Oxford University Press
The Journal of Infectious Diseases, 227(5), 651-662. Oxford University Press
Jongkees, M J, Geers, D, Hensley, K S, Huisman, W, GeurtsvanKessel, C H, Bogers, S, Gommers, L, Papageorgiou, G, Jochems, S P, den Hollander, J G, Schippers, E F, Ammerlaan, H S M, Bierman, W F W, van der Valk, M, Berrevoets, M A H, Soetekouw, R, Langebeek, N, Bruns, A H W, Leyten, E M S, Sigaloff, K C E, van Vonderen, M G A, Delsing, C E, Branger, J, Katsikis, P D, Mueller, Y M, de Vries, R D, Rijnders, B J A, Brinkman, K, Rokx, C & Roukens, A H E 2023, ' Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination ', The Journal of infectious diseases, vol. 227, no. 5, pp. 651-662 . https://doi.org/10.1093/infdis/jiac451
The Journal of infectious diseases, 227(5), 651-662. Oxford University Press
BackgroundThe COVIH study is a prospective coronavirus disease 2019 (COVID-19) vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels after primary vaccination. We evaluated whether an additional vaccination boost
Autor:
Jara R. de la Court, Jarom Heijmans, Jennifer Huynh, Elske Sieswerda, Nick A. de Jonge, Karin van Dijk, Kim C. E. Sigaloff, Rogier P. Schade
Publikováno v:
de la Court, J R, Heijmans, J, Huynh, J, Sieswerda, E, de Jonge, N A, van Dijk, K, Sigaloff, K C E & Schade, R P 2022, ' Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients : a retrospective cohort study ', Antimicrobial Resistance and Infection Control, vol. 11, no. 1, 160 . https://doi.org/10.1186/s13756-022-01198-5
Antimicrobial resistance and infection control, 11(1):160. BioMed Central
Antimicrobial Resistance and Infection Control, 11(1):160. BioMed Central
Antimicrobial resistance and infection control, 11(1):160. BioMed Central
Antimicrobial Resistance and Infection Control, 11(1):160. BioMed Central
Background In neutropenic patients, bloodstream infections (BSI) significantly contribute to morbidity and mortality. Appropriate empirical antibiotic therapy (EAT) of BSI is essential, at the same time overconsumption of very broad-spectrum antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb00c4eb2b178635cc47e83826212de6
https://research.vumc.nl/en/publications/880673a7-3f54-485b-a1bf-a94bedcc419b
https://research.vumc.nl/en/publications/880673a7-3f54-485b-a1bf-a94bedcc419b